Presentation CTO 2026 Safety and Effectiveness of Saphenous Vein Grafts for Retrograde CTO PCI Presenter: Michaella Alexandrou February 14, 2026
Presentation CTO 2026 Native Coronary Artery Instead of Saphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions (NASA Registry) Presenter: Michaella Alexandrou February 13, 2026
News Daily News Side Effects of Statins Might Be Overstated: CTT Collaboration Michael O'Riordan February 12, 2026
News Daily News Both Low-fat and Low-carb Diets Tied to Less Heart Disease Michael O'Riordan February 11, 2026
News Daily News In-Hospital STEMI Patients Face Reperfusion Delays and Worse Outcomes Michael O'Riordan February 06, 2026
News Conference News STS 2026 New TAVI Explant Risk Model Reflects Growing Experience Yael L. Maxwell January 30, 2026
News Daily News Even With Optimized GDMT, HFrEF Prognosis Remains Dire Michael O'Riordan January 30, 2026
Podcast Heart Valve Matters Key Updates and Clinical Implications from the 2025 ESC/EACTS Guidelines for Valvular Heart Disease January 29, 2026
News Daily News Cardioprotective Flush, Without Reanimation, Safe and Effective in DCD Transplant Michael O'Riordan January 28, 2026
News Daily News FAME 2 at 10 Years: Less Urgent Revascularization With FFR-Guided PCI Michael O'Riordan January 26, 2026
News Daily News Telemedicine May Adversely Impact Care Quality for HF Patients Caitlin E. Cox January 26, 2026
News Daily News Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators Michael O'Riordan January 22, 2026
News Daily News Public Reporting Tied to Better Care, but Similar Outcomes, in Stroke Centers Todd Neale January 16, 2026
News Daily News Periprocedural MI Signals Worse Outcomes in Stented NSTE ACS Patients: MATRIX Michael O'Riordan January 15, 2026
Podcast Heart Valve Matters Modernizing the Data Infrastructure for Clinical Research January 15, 2026
News Daily News Easy Exercise Prevents Mortality in Cardio-Kidney-Metabolic Syndrome Yael L. Maxwell January 12, 2026
News Daily News Weight Regained Within 18 Months of Stopping GLP-1 Drugs Michael O'Riordan January 08, 2026